Yep. Some stopped paying attention and people lost their marbles when the NGIO IPO details were not forthcoming. Probably some had disappointment thinking we would be finished with pre-clinical work and the IND submission would be announced. I understand both frustrations but I also don't mind waiting another week if needbe on the test results. The NGIO IPO is more frustrating. Who knows what back and forth has to happen with the NAZ and how any of that may affect the S-1's, if at all.
(2)
(0)
Generex Biotechnology Corp. (GNBTQ) Stock Research Links